Physician profile
Scott Marrus
NPI 1063578284
$1,485.50
in general payments reported to CMS, 2019-2025
11 companies · $96.52 in 2025
The $96.52 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.64 · 2020: $25.98 · 2021: $421 · 2022: $112 · 2023: $504 · 2024: $314 · 2025: $96.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486 · Long Term Medical Supply Or Device Loan: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.88 |
| Long Term Medical Supply Or Device Loan | $429.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eko Health, INC. | $917.98 | 2021-2023 | |
| Pfizer INC. | $151.65 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $137.80 | 2024-2025 | Camzyos |
| Abbott Laboratories | $69.40 | 2021-2024 | Cardiomems |
| Cvrx, INC. | $50.35 | 2022-2025 | Barostim Neo System |
| Abiomed | $40.34 | 2024 | Impella |
| Medtronic, INC. | $30.92 | 2022 | |
| Novartis Pharmaceuticals Corporation | $28.49 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.98 | 2020 | |
| Heartflow, INC. | $20.95 | 2025 | |
| Preventice Services, LLC | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Marrus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.